Evaluation of 3D DL oZTEo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients ≥18 years of age

• Hand radiographs performed within the past 3-6 months with imaging results available for analysis

• Hand radiographs confirm the presence of bony erosions

• Scheduled for a hand MRI as part of their routine clinical care at Mayo Clinic Rochester

Locations
United States
Minnesota
Mayo Clinic in Rochester
RECRUITING
Rochester
Contact Information
Primary
Naveen S Murthy, MD
Murthy.Naveen@mayo.edu
507-284-8548
Time Frame
Start Date: 2024-12-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 25
Treatments
Experimental: oZTEo MRI pulse sequence
All patients will have the FDA approved MRI pulse sequence, oZTEo, added to their already ordered standard of care MRI examination.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic
Collaborators: GE Healthcare

This content was sourced from clinicaltrials.gov